XML 38 R26.htm IDEA: XBRL DOCUMENT
v3.24.3

Stockholders’ Equity (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Equity [Abstract] |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Research and development |  | $ | 58,168 |  |  | $ | 92,034 |  |  | $ | 171,033 |  |  | $ | 270,776 |
General and administrative |  |  | 49,726 |  |  |  | 66,056 |  |  |  | 138,432 |  |  |  | 229,951 |
Total |  | $ | 107,894 |  |  | $ | 158,090 |  |  | $ | 309,465 |  |  | $ | 500,727 |
Schedule of Key Assumption of Fair Value of Stock Options Granted | For options granted during the nine months ended September 30, 2024 and 2023, the Company calculated the fair value of each option grant on the respective dates of grant using the following weighted average assumptions: Schedule of Key Assumption of Fair Value of Stock Options Granted
|  | 2024 |  |  | 2023 |
Expected term |  |  | 5.76 years |  |  |  | 5.73 years |
Risk-free interest rate |  |  | 4.32 | % |  |  | 3.73 | %
Expected dividend yield |  |  | — |  |  |  | — |
Expected volatility |  |  | 97.78 | % |  |  | 98.97 | %
Schedule of Stock Option Activity | A summary of stock option activity is as follows: Schedule of Stock Option Activity
|  | Outstanding stock options |
|  | Number of shares |  |  | Weighted average exercise price |
Balance at December 31, 2023 |  |  | 262,247 |  |  | $ | 34.21 |
Options granted |  |  | 34,446 |  |  |  | 4.77 |
Options exercised |  |  | - |  |  |  | - |
Options forfeited |  |  | - |  |  |  | - |
Options cancelled |  |  | (10,209 | ) |  |  | 142.99 |
Balance at September 30, 2024 |  |  | 286,484 |  |  |  | 26.79 |
Options exercisable at September 30, 2024 |  |  | 224,430 |  |  |  | 32.33 |
Schedule of Share-based Compensation of Stock Options Outstanding and Exercisable | The following table summarizes information about stock options outstanding and exercisable at September 30, 2024: Schedule of Share-based Compensation of Stock Options Outstanding and Exercisable
| Options outstanding |  |  |  | Options exercisable |
| Number outstanding |  |  |  | Weighted average remaining contractual life (Years) |  |  |  | Weighted average exercise price |  |  |  | Aggregate intrinsic value |  |  |  | Number exerciseable |  |  |  | Weighted average remaining contractual life (Years) |  |  |  | Weighted average exercise price |  |  |  | Aggregate intrinsic value |
| 286,484 |  |  |  | 6.50 |  |  | $ | 26.79 |  |  | $ | 13,069 |  |  |  | 224,430 |  |  |  | 5.85 |  |  | $ | 32.33 |  |  | $ | - |
Summary of Restricted Stock Unit Activity | A summary of restricted stock unit activity is as follows: Summary of Restricted Stock Unit Activity
|  | Number of Unvested Restricted Stock Units |
Balance at December 31, 2023 |  |  | - |
Granted |  |  | 21,762 |
Vested |  |  | - |
Cancelled |  |  | - |
Balance at September 30, 2024 |  |  | 21,762 |
Schedule of Fair Value of Warrants | Schedule of Fair Value of Warrants
|  | September 30, 2024 |  |  | December 31, 2023 |
Expected life in years |  |  | 0.13 |  |  |  | 0.88 |
Risk-free interest rate |  |  | 4.87 | % |  |  | 4.79 | %
Dividend yield |  |  | — |  |  |  | — |
Volatility |  |  | 107.82 | % |  |  | 100.00 | %
Stock price |  | $ | 4.49 |  |  | $ | 2.79 |
Schedule of Reconciliation of Warrant Liability | Schedule of Reconciliation of Warrant Liability
|  | Warrant Liability |
Balance at December 31, 2023 |  | $ | 17,166 |
Change in fair value of common stock warrants |  |  | (13,580 | )
Balance at September 30, 2024 |  | $ | 3,586 |
Schedule of Number of Warrants Outstanding and the Weighted Average Exercise Price | The following table summarizes the number of common stock warrants outstanding and the weighted average exercise price: Schedule of Number of Warrants Outstanding and the Weighted Average Exercise Price
|  | Warrants |  |  | Weighted Average Exercise Price |
Outstanding at December 31, 2023 |  |  | 113,795 |  |  | $ | 8.72 |
Issued |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |
Cancelled |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |
Balance at September 30, 2024 |  |  | 113,795 |  |  | $ | 8.72 |
Schedule of Common Stock Warrants Outstanding | The following table summarizes information about common stock warrants outstanding at September 30, 2024: Schedule of Common Stock Warrants Outstanding
Warrants outstanding
Number exercisable |  | Weighted average remaining contractual life (Years) |  |  | Weighted average exercise price |  |  | Aggregate intrinsic value |
113,795 |  |  | 0.25 |  |  | $ | 8.72 |  |  | $ | - |

X
- Definition Schedule of common stock warrants outstanding [Table Text Block] + References No definition available. + Details
Name: | LPCN_ScheduleOfCommonStockWarrantsOutstandingTableTextBlock
Namespace Prefix: | LPCN_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of Fair Value of Warrants [Table Text Block] + References No definition available. + Details
Name: | LPCN_ScheduleOfFairValueOfWarrantsTableTextBlock
Namespace Prefix: | LPCN_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of Reconciliation of Warrant Liability [Table Text Block] + References No definition available. + Details
Name: | LPCN_ScheduleOfReconciliationOfWarrantLiabilityTableTextBlock
Namespace Prefix: | LPCN_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (e)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration